Limitless Life Nootropics vs Paradigm Peptide
Independent side-by-side comparison across the 1 peptides both vendors sell. Composite scores, lab quality, and verified pricing.
Limitless Life Nootropics
14 peptides covered with 58 lab tests. BPC-157 averages 6.6 across 6 tests with consistency penalty triggered.
Limitless Life Nootropics full review →Paradigm Peptide
Top Retatrutide vendor by score (9.0 across 14 tests). Strong on metabolic peptides.
Paradigm Peptide full review →Side-by-side breakdown
| PEPTIDE | LIMITLESS LIFE NOOTROPICS | PARADIGM PEPTIDE | WINNER |
|---|---|---|---|
| Ipamorelin |
7.2
B (4 tests)
|
9.0
A (6 tests)
|
Paradigm Peptide |
| GHK-Cu |
6.5
B (5 tests)
|
—(not sold)
|
Limitless Life Nootropics only |
| BPC-157 |
6.4
B (6 tests)
|
—(not sold)
|
Limitless Life Nootropics only |
| Semaglutide |
6.4
B (5 tests)
|
—(not sold)
|
Limitless Life Nootropics only |
| Tirzepatide |
—(not sold)
|
8.4
B+ (14 tests)
|
Paradigm Peptide only |
| Retatrutide |
—(not sold)
|
7.0
B (14 tests)
|
Paradigm Peptide only |
Which to choose
Across the 1 peptides both vendors sell, Limitless Life Nootropics scores higher on 0, Paradigm Peptide scores higher on 1, and 0 are within 0.3 points (effectively tied). Paradigm Peptide additionally sells Tirzepatide, Retatrutide; Limitless Life Nootropics does not. Limitless Life Nootropics additionally sells GHK-Cu, BPC-157, Semaglutide; Paradigm Peptide does not.
Choose Paradigm Peptide for: Ipamorelin.
Composite scores reflect lab quality, sentiment, COA transparency, reliability, and price. How we score.
Full profiles: Limitless Life Nootropics review · Paradigm Peptide review